Case Report of Chronic Eosinophilic Leukemia Associated with Long-Term
Use of Infliximab
- William Morse
, - Haroon Nawaz,
- Ayesha Choudhry
Abstract
We present a patient who has been diagnosed with Hypereosinophilic
syndrome, later determined to be chronic eosinophilic leukemia, after
long-term treatment with infliximab for ulcerative colitis. Follow-up
immunochemistry showed that discontinuation of infliximab improved the
polyclonality of eosinophils in our patient.17 Jan 2022Submitted to Clinical Case Reports 03 Oct 2022Submission Checks Completed
03 Oct 2022Assigned to Editor
03 Oct 2022Reviewer(s) Assigned
08 Oct 2022Review(s) Completed, Editorial Evaluation Pending
08 Oct 2022Editorial Decision: Revise Minor
